Investors

This section of the website provides financial reports, investor presentations, information on key corporate transactions and much more.

We strive to be transparent, relevant and accurate in presenting our financial information, in order to inform our stakeholders of the company’s operations and financial position.

If you have any questions, please don’t hesitate to contact us at investors@c-rad.com
Svensk version här

Sign up to our newsletter to keep up to date with investor news

Five reasons to invest in C-RAD

  • Contributing to improved cancer care and ultimately saving human life
  • Several factors point towards surface tracking becoming standard of care – which will unleash a vast market potential for C-RAD with exponential revenue growth
  • C-RAD has a proven and recognized product
  • C-RAD has comprehensive market access with a direct sales force, distributors, and direct cooperation with OEM-vendors
  • C-RAD has a stable financial platform – profitable growth, debt free and +100 MSEK in cash
Learn more

Press releases

2022-03-18 10:00 Tyskt universitetssjukhus väljer C-RAD’s banbrytande SGRT-lösning News Corporate Information Sales Order Swedish Regulatory MAR IR
2022-03-18 10:00 German University Hospital selects C-RAD’s cutting-edge SGRT solution News Corporate Information Sales Order English Regulatory MAR IR
2022-03-07 09:00 Guidelines highlighting the clinical implementation of surface imaging published by AAPM News Corporate Information Other Corporate Information English IR
2022-03-02 09:00 Belgium’s Iridium Network adopts C-RAD’s surface tracking solutions into their workflow News Corporate Information Other Corporate Information English IR
2022-01-27 08:30 RECORD HIGH IN ORDER INTAKE, REVENUE AND OPERATING INCOME News English Regulatory MAR Report Interim Yearend IR

Shares & stock

Please feel free to contact us regarding investments or other financial questions

If you have any questions, please don’t hesitate to contact us